GlassScriptPhysician profile
Sommer C Clark
NPI 1336382282
$1,501.21
in general payments reported to CMS, 2019-2025
21 companies · $335 in 2025
The $335 reported for 2025 was more than what 87% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $182 · 2022: $281 · 2023: $331 · 2024: $372 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,038.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,038.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $243.48 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $208.65 | 2022-2024 | Jornay Pm |
| Cranial Technologies, INC | $164.83 | 2022-2025 | Doc Band |
| Pfizer INC. | $124.82 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $119.31 | 2021-2025 | Vaxelis, M-M-R II, Gardasil 9 |
| Supernus Pharmaceuticals, INC. | $110.65 | 2021-2025 | Qelbree |
| Sanofi Pasteur INC. | $66.26 | 2021-2024 | |
| Noven Therapeutics, LLC | $62.47 | 2025 | Xelstrym, Secuado |
| Seqirus USA INC | $57.77 | 2023-2024 | Flucelvax, Flucelvax Quadrivalent |
| Collegium Pharmaceutical, INC. | $57.59 | 2025 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $41.76 | 2021-2022 | |
| Neurelis, INC. | $36.62 | 2022-2023 | Valtoco |
| Alk-Abello, INC | $32.52 | 2024 | Grastek, Ragwitek, Odactra |
| Glaxosmithkline, LLC. | $26.84 | 2023 | Bexsero |
| Neos Therapeutics, LP | $26.83 | 2022-2024 | Adzenys Xr-Odt |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $25.53 | 2022-2023 | Dyanavel Xr |
| Sobi, INC | $25.23 | 2022-2023 | |
| Hologic Sales and Service, LLC | $21.99 | 2025 | Aptima |
| Lnhc, INC | $21.31 | 2025 | Zelsuvmi |
| Ultragenyx Pharmaceutical INC. | $15.82 | 2021 | |
| Organon LLC | $10.93 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sommer Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.